It was also shown that 15% (6/40) of patients with CC had point mutations in the tyrosine kinase domain of the EGFR of patients with ICC (K575R, E872K, T790M), ECC (C775Y, G882S, V843I, L858R), and GBC (A864T). The gene discussed is EGFR; the disease is cholangiocarcinoma.